Clinical Trial Update: The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3 [NA]

View source ↗

Summary

The clinical trial evaluating variability in response to calcifediol (25-hydroxyvitamin D3) for vitamin D deficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitamin Deficiency

Drugs mentioned

• Calcifediol (calcifediol (25-hydroxyvitamin D3))

Snippet

Sponsor: Creighton University | Conditions: Vitamin D Deficiency | NA | Status: WITHDRAWN